2020 Annual Meeting | C110 - Resident Basic Science 3: Neuropathology

�鶹��ýӳ��

2020 Annual Meeting | C110 - Resident Basic Science 3: Neuropathology

Date Monday 04/27/20

Time 01:00 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Suzanne Powell, MD

Topic(s) Research Methodology, �鶹��ýӳ��, and History

Learning Objectives Participants should be able to recognize common gross, histological, and molecular features of central nervous system disorders, and be able to understand cellular and gross neuropathology in relationship to neurologic disease mechanisms, diagnosis, progression, laboratory studies, and imaging.

CME Available 3.75 CME credits

Core Competencies Medical Knowledge

Program Level Introductory

Program Tracks Advanced Practice Provider, Academic

Recommended Audience Fellow, Resident, General Neurologist, Medical Student

Teaching Styles Didactic, Audience Participation

Event Timeline
01:00 PM - 01:20 PM	Introduction	Approach to Neuropathological Interpretation Suzanne Powell, MD
01:20 PM - 02:40 PM	Speaker	Tumors Suzanne Powell, MD
02:40 PM - 02:55 PM	Speaker	Demyelinating Disorders J. Clay Goodman, MD, F�鶹��ýӳ��
02:55 PM - 03:15 PM	Break	Break
03:15 PM - 03:45 PM	Speaker	Vascular Diseases J. Clay Goodman, MD, F�鶹��ýӳ��
03:45 PM - 04:15 PM	Speaker	Neurodegenerative Diseases J. Clay Goodman, MD, F�鶹��ýӳ��
04:15 PM - 04:40 PM	Speaker	Infections J. Clay Goodman, MD, F�鶹��ýӳ��
04:40 PM - 04:50 PM	Speaker	Toxic Metabolic Disorders J. Clay Goodman, MD, F�鶹��ýӳ��
04:50 PM - 05:00 PM	Speaker	Trauma J. Clay Goodman, MD, F�鶹��ýӳ��
05:00 PM - 05:30 PM	Q&A	Questions and Answers

Faculty Disclosures
Suzanne Powell, MD	Dr. Powell has nothing to disclose.
J. Clay Goodman, MD, F�鶹��ýӳ��	Dr. Goodman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Board of Psychiatry and Neurology (ABPN). The institution of an immediate family member of Dr. Goodman has received research support from NIH.